ABSTRACT We induced chronic pulmonary hypertension in one group of rats by exposing them to chronic hypobaric hypoxia (380 mm Hg for three weeks) and in another group by administering a single subcutaneous dose of monocrotaline (60 mg/kg body weight). Both groups of rats showed increase of the right ventricular mean systolic blood pressure and right ventricular hypertrophy. We measured the surface area of histological sections of the left or right lungs and counted all small blood vessels with an external diameter of less than 50 Am and with a definite elastic coat lying distal to respiratory bronchioles. In the 10 rats with chronic hypoxic pulmonary hypertension the mean total number of small pulmonary blood vessels was 428-8 ± 96-9 (SD) compared with 337-8 ± 91h9 in 10 untreated control rats. The number of small pulmonary blood vessels per mm2 of lung tissue was 4 0 ± 1 3 in the chronically hypoxic rats compared with 3-8 ± 1 2 in the controls. The mean total number of small pulmonary blood vessels in nine rats with monocrotaline-induced pulmonary hypertension was 396-8 ± 61[7 compared with 384 55A4 in three control rats. The number of small pulmonary blood vessels per mm2 lung tissue was 3-3 06 in the rats treated with monocrotaline compared with 3.6 ± 0.6 in the control group. We conclude that the number of small pulmonary blood vessels is not reduced in rats with pulmonary hypertension induced by chronic hypoxia or monocrotaline.
Chronic pulmonary arterial hypertension can be induced in rats either by inducing chronic hypoxia' or by administering the pyrrolizidine alkaloid monocrotaline.2
In both these experimental models the pulmonary hypertension is accompanied by muscularisation of pulmonary arterioles and right ventricular hypertrophy. In the case of monocrotaline pulmonary hypertension, the muscular pulmonary arteries develop medial hypertrophy and sometimes show necrotising arteritis. It was suggested by one group of workers that a factor in the development of increased pulmonary vascular resistance in both monocrotaline pulmonary hypertension3 and chronic hypoxic pulmonary hypertension4 is a reduction in the number of small pulmonary arteries. This suggestion was based on visual assessment of postmortem angiograms, measurements of arterial number per unit area, and estimates of the ratio of arterial to alveolar number in histological sections. This view has been challenged, however, by another group of workers, who used labelled albumin to measure the pulmonary vascular volume in rats. They found that the total vascular volume of the left lung was not significantly different in Reprint requests to: Dr. JM Kay. Departinent ot Laboratory Medicine, St Joseph's Hospital. Haiiiilton. Ontario L8N IY4. Canada. chronically hypoxic and control groups of rats, despite lower body weight in the former group. Recently we have studied the development of pulmonary hypertension, pulmonary vascular disease, and right ventricular hypertrophy in rats exposed to chronic hypobaric hypoxia6 7 and rats given a single subcutaneous injection of monocrotaline.8 In these experiments all the small pulmonary blood vessels measuring less than 50 ,um in diameter were counted in histological sections of either the left or the right lung. Since it is important to know whether there is destruction of the pulmonary vascular bed in pulmonary hypertension, we have re-examined the data from our experiments to determine whether or not there was a reduction in small pulmonary blood vessels in rats subjected to chronic hypoxia or treated with monocrotaline.
Methods

CHRONIC HYPOXIC PULMONARY HYPERTENSION
Twenty female Wistar rats were divided into control and test groups of equal number. The initial mean body weights of the two groups 71 2 ± 6-6 g (SD) and 75*7 + 13-2 g. The 10 test rats were confined in a cylindrical steel hypobaric chamber, which was initially decompressed to 927 460 mm Hg. The pressure was progressively reduced in daily stages so that after one week it was 380 mm Hg. The rats remained at this pressure for a further two weeks. After three weeks of chronic hypoxia, the right ventricular mean systolic blood pressure (Prvs) was measured in the control and test rats by cannulating the right external jugular vein under light ether anaesthesia. The rats were then killed and the thoracic organs removed. The trachea was cannula'ted and the lungs were distended with 13 ml of 10% formol saline, which ensured that the pleural surfaces were smooth. The trachea was then ligated, the cannula withdrawn and the viscera immersed in 10% formol saline until fixation was complete. The hearts were dissected and right ventricular hypertrophy was evaluated by expressing the weight of the free wall of the right ventricle as a percentage of the weight of the left ventricle and interventricular septum. A single block of the entire left lung cut in the parasagittal plane was routinely processed for histological examination. Sections were stained by the Miller elastic-Van Gieson method9 for distinguishing smooth muscle, collagen, and elastic tissue. The small pulmonary blood vessels were evaluated by the method described below.
MONOCROTALINE-IN DUCED PULMONARY HYPERTENSION
We studied a group of nine test rats and a group of three control rats whose respective initial mean body weights were 123-7 g ± 5*8 and 108*3 g ± 11 9. Each test rat was given a single subcutaneous injection of a 2% aqueous solution of monocrotaline hydrochloride. The dose of monocrotaline was 60 mg/kg body weight. On the 14th, 17th, and 22nd days after the injection of monocrotaline the Prvs was measured in one control and three test rats. The rats were then killed and the cervical and thoracic organs removed in one block. The left main bronchus was clamped and ligated, after which the left lung was removed for enzyme assay.8 The trachea was cannulated and the right lung was distended by injecting 7 ml of 10% formol saline, which ensured that the pleural surfaces were smooth. The trachea was then ligated, the cannula withdrawn and the remaining thoracic viscera immersed in 10% formol saline until fixation was complete. The hearts were dissected and right ventricular hypertrophy was evaluated as described above. A block of tissue was cut from each of the superior, middle, inferior, and median lobes of the right lung of every animal and was routinely processed for histological examination. Sections stained by the Miller elastic-Van Gieson method were used for assessment of the small pulmonary blood vessels as described below.
EVALUATION OF SMALL PULMONARY BLOOD VESSELS
The muscular pulmonary artery in a rat is defined as an arterial vessel with an external diameter of between 20 Kay, Suyama, Keane and 400 um. It has a tunica media of circularly oriented smooth muscle sandwiched between two elastic laminae. The pulmonary arteriole in a rat is an arterial vessel with an external diameter of under 20 Am whose wall is normally devoid of smooth muscle except adjacent to its origin from a muscular pulmonary artery. It consists'of a single elastic lamina lined by endothelium. Pulmonary venules are structurally identical to pulmonary arterioles and these cannot be distinguished from one another unless they can be traced to a larger vessel. We used the technique of Hunter and coworkers to assess the small pulmonary blood vessels. 10 The histological sections of lung were systematically examined with the x40 objective in a microscope fitted with a calibrated eyepiece micrometer. All small blood vessels less than 50 ,um external diameter with a definite elastic coat lying distal to respiratory bronchioles were counted. These vessels lie adjacent to alveolar ducts or alveolar spaces. The counts included small muscular pulmonary arteries, normal pulmonary arterioles, and, in the case of rats with pulmonary hypertension, muscularised pulmonary arterioles. The counts of vessels also included occasional small venules, which could not be distinguished from normal pulmonary arterioles. After the vessels had been counted the histological sections were inserted into a Kodak Carousel 750 slide projector and images were projected on to paper at a distance of 3 m. The sections of lung were outlined on the paper with a pencil. The images were then cut out and weighed using a Sartorius semimicro analytical balance. The area of each lung section was calculated by comparing the weight of the paper images with the weight of a square centimetre projected on to identical paper at the same distance. All sections were coded and examined without knowledge of whether they were' derived from control or test rats.
The results of the two experiments expressed as means with SD were evaluated with the t test for unpaired data. Differences in mean values were considered to be significant when p < 0 05.
Results
In the table are shown the initial and final body weights, Prvs, right ventricular weight, number of small pulmonary blood vessels, and area of lung sections in control rats and rats with pulmonary hypertension due to chronic hypoxia or to monocrotaline. The groups of rats exposed to chronic hypoxia and given monocrotaline both had pulmonary hypertension associated with right ventricular ,hypertrophy. Both types of treatment interfered with normal growth and so the final body weights of the two groups of test rats were lower than their respective control groups. Despite this reduction in body weight, the area of the lung sections was increased in both the chronically hypoxic rats and those treated with monocrotaline. The total number of small pulmonary blood vessels was n= 10 except where otherwise stated. v n = 9 except where otherwisestated. Prvs-right ventricular mean systolic blood pressure; RV-weight ot free wall of right ventricle; LV + S-weight ot left ventricle and interventricular septum; SPBV-small pulmonary blood vessels.
significantly increased in the chronically hypoxic rats.
When this number was expressed per unit area of lung tissue, however, there was no significant difference between test and control groups. In the rats with monocrotaline-induced pulmonary hypertension the total number of small pulmonary blood vessels was increased but the difference between test and control values did not achieve significance. Similarly, there was no significant difference between the monocrotaline test and control groups when the number of small pulmonary blood vessels was expressed per unit area of lung tissue.
Discussion
The first report of a reduction in pulmonary arteries in monocrotaline pulmonary hypertension was published by Hislop and Reid in 1974 . These workers fed male Sprague-Dawley rats weighing 170-192 g a diet containing powdered C'rotalairia spectabilis seeds. These seeds contain the pyrrolizidine alkaloid monocrotaline. After 34 days the test rats showed right ventricular hypertrophy and an increase in the medial thickness of muscular pulmonary arteries. The number of small pulmonary arteries was reduced from 8-51 per mm2 in control rats to 4-63 per mm2 in rats fed Crotalaria spectabilis seeds. The ratio of the number of alveoli to the number of arteries increased from 26-61 in control animals to 49-98 in test rats. In 1976 the same group of workers exposed male Sprague-Dawley rats weighing 175-225 g to hypobaric hypoxia (380 mm Hg) for three to 28 days.4 After 14 days' exposure the number of pulmonary arteries measuring less than 200 ,um diameter was reduced by 40%.
We are unable to confirm the results of Hislop and Reid with regard to either monocrotaline-induced pulmonary hypertension or chronic hypoxic pulmonary hypertension. Rather our findings support the work of Hunter et al,'0( who found no reduction in the number of small arteries in male Wistar rats living in a decompression chamber at 390 mm Hg. In a similar study Leach (quoted by Emery et a1l5) counted all small vessels less than 50 ,um in diameter in the left lung of rats and found no evidence of a loss of vessels in animals exposed to 8% or 10% oxygen. Specifically, the mean number of vessels was 342 ± 40 (SEM) in 50 control rats and 332 ± 12 in 50 chronically hypoxic rats. Recently Emery and her colleagues5 investigated this problem using a different method. They perfused the lungs of control rats and chronically hypoxic rats kept in 10% oxygen for three to six weeks with a solution containing human serum albumin labelled with radioactive iodine. The vascular volume of the left lung was then calculated from measurements of gamma emissions. The method was sensitive enough to detect changes in vascular volume with growth. They found that the vascular volume of the lung in the chronically hypoxic rats was not reduced. In fact, it was large for the body size and normal for the age of the rats.
When pulmonary blood vessels become obliterated as a result of fibrosing diseases of the lung' or thrombotic occlusion, their previous existence can be inferred by recognition of nodules of fibroelastic tissue. We have never seen such evidence of vascular obliteration in rats with pulmonary hypertension due to chronic hypoxia or monocrotaline. Hislop and Reid saw no sign of "lost" vessels in their rats with pulmonary hypertension due to chronic hypoxia despite a 40% reduction in the number of pulmonary arteries.4 In their rats fed Crotarlaria spectabilis seeds they described non-muscular, partially muscular, and muscular "ghost" arteries in which the lumen was reduced or blocked by enlarged intimal cells. 
